Skip to main content
Clinical Trials/NCT00712478
NCT00712478CompletedNot Applicable

Observational Study on Efficacy of Intensification of Insulin Therapy to at Least 3 Daily Injections in Type 2 Diabetes

Novo Nordisk A/S0 sites114 target enrollmentStarted: September 2007Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
114
Primary Endpoint
Evaluate improvement of diabetes control with fasting glycemia and after diner glycemia measurements

Study Overview

Brief Summary

This study is conducted in Europe. The aim of this observational study is to determine diabetes control improvement, during the third month of follow-up after insulin intensification to at least 3 daily insulin injections, in assessing the proportion of uncontrolled fasting and postprandial glycaemia values recorded on a diary.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
40 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Type 2 diabetes patients
  • Treatment with two insulin daily injections and needing insulin intensification regimen to at least three daily injections
  • HbA1c greater than or equal to 8.0%

Exclusion Criteria

  • Patients not performing glycaemia self-measurements
  • Secondary diabetes
  • Requirement of or use of an insulin pump
  • Treatment with corticoids

Arms & Interventions

A

Intervention: insulin (Drug)

Outcomes

Primary Outcomes

Evaluate improvement of diabetes control with fasting glycemia and after diner glycemia measurements

Time Frame: After 3 months

Secondary Outcomes

  • Evaluate improvement of diabetes control with fasting glycemia and after diner glycemia measurements(After first 2 months)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Similar Trials

Observational Study Describing Conditions... | Clinical Trial